148 related articles for article (PubMed ID: 34930399)
1. Low thyroid hormone receptor alpha-2 (THRα-2) tumor expression is associated with unfavorable tumor characteristics and high breast cancer mortality.
Sandsveden M; Borgquist S; Rosendahl AH; Manjer J
Breast Cancer Res; 2021 Dec; 23(1):117. PubMed ID: 34930399
[TBL] [Abstract][Full Text] [Related]
2. Androgen Receptor Expression and Breast Cancer Survival: Results From the Nurses' Health Studies.
Kensler KH; Poole EM; Heng YJ; Collins LC; Glass B; Beck AH; Hazra A; Rosner BA; Eliassen AH; Hankinson SE; Winer EP; Brown M; Tamimi RM
J Natl Cancer Inst; 2019 Jul; 111(7):700-708. PubMed ID: 30445651
[TBL] [Abstract][Full Text] [Related]
3. Prospectively measured thyroid hormones and thyroid peroxidase antibodies in relation to risk of different breast cancer subgroups: a Malmö Diet and Cancer Study.
Brandt J; Borgquist S; Manjer J
Cancer Causes Control; 2015 Aug; 26(8):1093-104. PubMed ID: 26033776
[TBL] [Abstract][Full Text] [Related]
4. Estrogen receptor quantitative measures and breast cancer survival.
Hill DA; Barry M; Wiggins C; Nibbe A; Royce M; Prossnitz E; Lomo L
Breast Cancer Res Treat; 2017 Dec; 166(3):855-864. PubMed ID: 28825224
[TBL] [Abstract][Full Text] [Related]
5. T3 levels in relation to prognostic factors in breast cancer: a population-based prospective cohort study.
Tosovic A; Bondeson AG; Bondeson L; Ericsson UB; Manjer J
BMC Cancer; 2014 Jul; 14():536. PubMed ID: 25060772
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of thyroid hormone receptor alpha and estrogen receptor alpha in breast cancer associated with thyroid cancer.
Kim YA; Kim YA; Cho SW; Song YS; Min HS; Park IA; Park DJ; Hwang KT; Park YJ
Eur J Surg Oncol; 2021 Jun; 47(6):1316-1323. PubMed ID: 33558123
[TBL] [Abstract][Full Text] [Related]
7. The prognostic effect of estrogen receptor status differs for younger versus older breast cancer patients.
Sopik V; Sun P; Narod SA
Breast Cancer Res Treat; 2017 Sep; 165(2):391-402. PubMed ID: 28601929
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of FOXP3+ tumor-infiltrating lymphocytes in breast cancer depends on estrogen receptor and human epidermal growth factor receptor-2 expression status and concurrent cytotoxic T-cell infiltration.
Liu S; Foulkes WD; Leung S; Gao D; Lau S; Kos Z; Nielsen TO
Breast Cancer Res; 2014 Sep; 16(5):432. PubMed ID: 25193543
[TBL] [Abstract][Full Text] [Related]
9. Assessment of 25-Year Survival of Women With Estrogen Receptor-Positive/ERBB2-Negative Breast Cancer Treated With and Without Tamoxifen Therapy: A Secondary Analysis of Data From the Stockholm Tamoxifen Randomized Clinical Trial.
Dar H; Johansson A; Nordenskjöld A; Iftimi A; Yau C; Perez-Tenorio G; Benz C; Nordenskjöld B; Stål O; Esserman LJ; Fornander T; Lindström LS
JAMA Netw Open; 2021 Jun; 4(6):e2114904. PubMed ID: 34190995
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological Characteristics and Breast Cancer-Specific Survival of Patients With Single Hormone Receptor-Positive Breast Cancer.
Li Y; Yang D; Yin X; Zhang X; Huang J; Wu Y; Wang M; Yi Z; Li H; Li H; Ren G
JAMA Netw Open; 2020 Jan; 3(1):e1918160. PubMed ID: 31899528
[TBL] [Abstract][Full Text] [Related]
11. Triiodothyronine levels in relation to mortality from breast cancer and all causes: a population-based prospective cohort study.
Tosovic A; Bondeson AG; Bondeson L; Ericsson UB; Manjer J
Eur J Endocrinol; 2013 Apr; 168(4):483-90. PubMed ID: 23258272
[TBL] [Abstract][Full Text] [Related]
12. High expression of long non-coding RNA MALAT1 in breast cancer is associated with poor relapse-free survival.
Wang Z; Katsaros D; Biglia N; Shen Y; Fu Y; Loo LWM; Jia W; Obata Y; Yu H
Breast Cancer Res Treat; 2018 Sep; 171(2):261-271. PubMed ID: 29845475
[TBL] [Abstract][Full Text] [Related]
13. Abnormal thyroid hormone receptor signaling in osteoarthritic osteoblasts regulates microangiogenesis in subchondral bone.
Li L; Li M; Pang Y; Wang J; Wan Y; Zhu C; Yin Z
Life Sci; 2019 Dec; 239():116975. PubMed ID: 31654748
[TBL] [Abstract][Full Text] [Related]
14. Effects of tumor-specific CAP1 expression and body constitution on clinical outcomes in patients with early breast cancer.
Bergqvist M; Elebro K; Sandsveden M; Borgquist S; Rosendahl AH
Breast Cancer Res; 2020 Jun; 22(1):67. PubMed ID: 32560703
[TBL] [Abstract][Full Text] [Related]
15. Abstract PS6-55: The prognostic utility of AR/ER ratio in young women with breast cancer.
Prabhu JS; Korlimarla A; Rajarajan S; Alexander A; Anupama C; Ramesh R; Srinath B; Sridhar TS
Cancer Res; 2021 Feb; 81(4 Suppl):. PubMed ID: 34421401
[TBL] [Abstract][Full Text] [Related]
16. Mode of detection and breast cancer mortality by follow-up time and tumor characteristics among screened women in Cancer Prevention Study-II.
Puvanesarajah S; Gapstur SM; Patel AV; Sherman ME; Flanders WD; Gansler T; Troester MA; Gaudet MM
Breast Cancer Res Treat; 2019 Oct; 177(3):679-689. PubMed ID: 31264062
[TBL] [Abstract][Full Text] [Related]
17. The Antiarrhythmic Drug, Dronedarone, Demonstrates Cytotoxic Effects in Breast Cancer Independent of Thyroid Hormone Receptor Alpha 1 (THRα1) Antagonism.
Elliott MJ; Jerzak KJ; Cockburn JG; Safikhani Z; Gwynne WD; Hassell JA; Bane A; Silvester J; Thu KL; Haibe-Kains B; Mak TW; Cescon DW
Sci Rep; 2018 Nov; 8(1):16562. PubMed ID: 30410118
[TBL] [Abstract][Full Text] [Related]
18. Estrogen receptor-positive, progesterone receptor-negative breast cancer: association with growth factor receptor expression and tamoxifen resistance.
Arpino G; Weiss H; Lee AV; Schiff R; De Placido S; Osborne CK; Elledge RM
J Natl Cancer Inst; 2005 Sep; 97(17):1254-61. PubMed ID: 16145046
[TBL] [Abstract][Full Text] [Related]
19. Thyroid function and survival following breast cancer.
Brandt J; Borgquist S; Almquist M; Manjer J
Br J Surg; 2016 Nov; 103(12):1649-1657. PubMed ID: 27599301
[TBL] [Abstract][Full Text] [Related]
20. Breast cancer-specific survival by clinical subtype after 7 years follow-up of young and elderly women in a nationwide cohort.
Johansson ALV; Trewin CB; Hjerkind KV; Ellingjord-Dale M; Johannesen TB; Ursin G
Int J Cancer; 2019 Mar; 144(6):1251-1261. PubMed ID: 30367449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
